KALA

KALA BIO, Inc.NASDAQHealthcare

$0.17+4.42%ClosedMarket Cap: $3.7M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2025-09-29	HC Wainwright & Co.	—	Neutral	—
2025-09-17	HC Wainwright & Co.	—	Buy	—
2025-09-11	Oppenheimer	—	Outperform	—
2025-05-23	HC Wainwright & Co.	—	Buy	—
2025-04-04	HC Wainwright & Co.	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Thu Dec 31	$-0.53	$25.0M	1
Fri Dec 31	$-0.40	$26.1M	1
Sun Dec 31	$-0.18	$134.2M	1
Mon Dec 31	$-0.17	$229.3M	1